Addus HomeCare Corp. (ADUS) is a publicly traded Healthcare sector company. As of May 21, 2026, ADUS trades at $93.76 with a market cap of $1.73B and a P/E ratio of 21.57. ADUS moved +1.26% today. Year to date, ADUS is -14.48%; over the trailing twelve months it is -16.67%. Its 52-week range spans $88.96 to $136.72. Analyst consensus is strong buy with an average price target of $130.00. Rallies surfaces ADUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
12 analysts cover ADUS: 0 strong buy, 10 buy, 1 hold, 1 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $130.00.
| Metric | Value |
|---|---|
| Price | $93.76 |
| Market Cap | $1.73B |
| P/E Ratio | 21.57 |
| EPS | $4.33 |
| Dividend Yield | 0.00% |
| 52-Week High | $136.72 |
| 52-Week Low | $88.96 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.15B |
| Net Income | $73.60M |
| Gross Margin | 32.48% |
12 analysts cover ADUS: 0 strong buy, 10 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $130.00.